Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology.

[1]  W. Busse,et al.  Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. , 2012, The Journal of allergy and clinical immunology.

[2]  Manuel A. R. Ferreira,et al.  Genome-Wide Association Studies of Asthma in Population-Based Cohorts Confirm Known and Suggested Loci and Identify an Additional Association near HLA , 2012, PloS one.

[3]  F. Liew,et al.  Interleukin-33 and the function of innate lymphoid cells. , 2012, Trends in immunology.

[4]  Peter Natesan Pushparaj,et al.  Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice1 , 2012, Allergy.

[5]  L. Wain,et al.  Genome-wide association study to identify genetic determinants of severe asthma , 2011, Thorax.

[6]  J. Park,et al.  Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation. , 2012, Biochemical and biophysical research communications.

[7]  Marjolein J. W. de Bruijn,et al.  Pulmonary innate lymphoid cells are major producers of IL‐5 and IL‐13 in murine models of allergic asthma , 2012, European journal of immunology.

[8]  P. Mercier,et al.  Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain , 2012, The Journal of Immunology.

[9]  P. Deloukas,et al.  Patterns of Cis Regulatory Variation in Diverse Human Populations , 2012, PLoS genetics.

[10]  Fumio Takei,et al.  Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. , 2012, Immunity.

[11]  S. Nakae,et al.  The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses , 2012, Science.

[12]  S. Woo,et al.  IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[13]  Daniel Capurso,et al.  Resequencing candidate genes implicates rare variants in asthma susceptibility. , 2012, American journal of human genetics.

[14]  H. Kita,et al.  IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs , 2012, The Journal of Immunology.

[15]  Freddy Radtke,et al.  Rorα is essential for nuocyte development , 2011, Nature Immunology.

[16]  R. Kinne,et al.  IL-33 regulates TNF-α dependent effects in synovial fibroblasts , 2012, International journal of molecular medicine.

[17]  Hergen Spits,et al.  Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 , 2011, Nature Immunology.

[18]  David Artis,et al.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus , 2011, Nature Immunology.

[19]  E. Trabetti,et al.  Association of childhood allergic asthma with markers flanking the IL33 gene in Italian families. , 2011, The Journal of allergy and clinical immunology.

[20]  Sangdun Choi,et al.  In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L , 2011, PloS one.

[21]  M. Schmitz,et al.  The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB–Stimulated Gene Transcription , 2011, The Journal of Immunology.

[22]  Ashley M. Miller,et al.  IL‐33 induces skin inflammation with mast cell and neutrophil activation , 2011, European journal of immunology.

[23]  Ya-Jen Chang,et al.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.

[24]  Ryan D. Hernandez,et al.  Meta-analysis of Genome-wide Association Studies of Asthma In Ethnically Diverse North American Populations , 2011, Nature Genetics.

[25]  M. Kawaguchi,et al.  Expression and Effects of IL-33 and ST2 in Allergic Bronchial Asthma: IL-33 Induces Eotaxin Production in Lung Fibroblasts , 2011, International Archives of Allergy and Immunology.

[26]  Manuel A. R. Ferreira,et al.  Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia , 2011, European Journal of Human Genetics.

[27]  D. Postma,et al.  Interleukin-1 receptor-like 1 polymorphisms are associated with serum IL1RL1-a, eosinophils, and asthma in childhood. , 2011, The Journal of allergy and clinical immunology.

[28]  G. Nilsson,et al.  Mast Cells as Sensors of Cell Injury through IL-33 Recognition , 2011, The Journal of Immunology.

[29]  J. Steinke,et al.  Interleukin-33 in Asthma: How Big of a Role Does It Play? , 2011, Current allergy and asthma reports.

[30]  Simon C. Potter,et al.  The Architecture of Gene Regulatory Variation across Multiple Human Tissues: The MuTHER Study , 2011, PLoS genetics.

[31]  Mousheng Xu,et al.  Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. , 2010, Human molecular genetics.

[32]  A. Matsuda,et al.  IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells , 2010, The Journal of Immunology.

[33]  Florence Demenais,et al.  A large-scale, consortium-based genomewide association study of asthma. , 2010, The New England journal of medicine.

[34]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[35]  J. Brehm,et al.  Analyses of shared genetic factors between asthma and obesity in children. , 2010, The Journal of allergy and clinical immunology.

[36]  Tsun-Po Yang,et al.  Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies , 2010, Bioinform..

[37]  Silke Szymczak,et al.  Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility , 2010, PloS one.

[38]  H. Redmond,et al.  ST2 Negatively Regulates TLR2 Signaling, but Is Not Required for Bacterial Lipoprotein-Induced Tolerance , 2010, The Journal of Immunology.

[39]  Q. Hamid,et al.  Increased IL-33 expression by epithelial cells in bronchial asthma. , 2010, The Journal of allergy and clinical immunology.

[40]  A. Margulis,et al.  IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation , 2010, Inflammation Research.

[41]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[42]  I. McInnes,et al.  Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.

[43]  S. London,et al.  Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. , 2010, The Journal of allergy and clinical immunology.

[44]  D. Postma,et al.  TLR‐related pathway analysis: novel gene–gene interactions in the development of asthma and atopy , 2010, Allergy.

[45]  Ingo Ruczinski,et al.  Variants of DENND1B associated with asthma in children. , 2010, The New England journal of medicine.

[46]  Tsutomu Takeuchi,et al.  Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.

[47]  I. McInnes,et al.  IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation1 , 2009, The Journal of Immunology.

[48]  John H. White,et al.  Asthma and genes encoding components of the vitamin D pathway , 2009, Respiratory research.

[49]  Qutayba Hamid,et al.  Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.

[50]  Andreas Lingel,et al.  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes. , 2009, Structure.

[51]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[52]  P. Deloukas,et al.  Common Regulatory Variation Impacts Gene Expression in a Cell Type–Dependent Manner , 2009, Science.

[53]  D. Postma,et al.  Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction , 2009, Nature Genetics.

[54]  C. Dahinden,et al.  Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. , 2009, Blood.

[55]  C. Hong,et al.  Alpha‐T‐catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate‐induced asthma by genome‐wide association analysis , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[56]  S. Fujieda,et al.  Association of serum interleukin‐33 level and the interleukin‐33 genetic variant with Japanese cedar pollinosis , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[57]  M. Teixeira,et al.  IL-33 induced Ag-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4 , 2008, The Journal of Immunology.

[58]  K. Ohta,et al.  An IL-1 Cytokine Member, IL-33, Induces Human Basophil Activation via Its ST2 Receptor1 , 2008, The Journal of Immunology.

[59]  L. Roussel,et al.  Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket , 2008, EMBO reports.

[60]  Richard T. Lee,et al.  The IL-33/ST2 pathway: therapeutic target and novel biomarker , 2008, Nature Reviews Drug Discovery.

[61]  D. Postma,et al.  Association of IL1RL1, IL18R1, and IL18RAP gene cluster polymorphisms with asthma and atopy. , 2008, The Journal of allergy and clinical immunology.

[62]  Dirk E. Smith,et al.  IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. , 2008, International immunology.

[63]  J. Fujimoto,et al.  Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. , 2008, International immunology.

[64]  H. Kita,et al.  A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. , 2008, The Journal of allergy and clinical immunology.

[65]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[66]  S. Akira,et al.  IL‐33 induces IL‐13 production by mouse mast cells independently of IgE‐FcεRI signals , 2007 .

[67]  I. McInnes,et al.  IL‐33 is a chemoattractant for human Th2 cells , 2007, European journal of immunology.

[68]  Dirk E. Smith,et al.  Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1 , 2007, The Journal of Immunology.

[69]  S. Galli,et al.  IL-33 can promote survival, adhesion and cytokine production in human mast cells , 2007, Laboratory Investigation.

[70]  L. O'Neill,et al.  Structure, function and regulation of the Toll/IL‐1 receptor adaptor proteins , 2007, Immunology and cell biology.

[71]  S. Hurd,et al.  GINA guidelines on asthma and beyond * , 2007, Allergy.

[72]  Delphine A. Lacorre,et al.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.

[73]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[74]  S. Tominaga,et al.  Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. , 2005, Human molecular genetics.

[75]  D. Fabian,et al.  The global burden of asthma: executive summary of the GINA Dissemination Committee Report , 2004, Allergy.

[76]  F. Liew,et al.  ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance , 2004, Nature Immunology.

[77]  A. McKenzie,et al.  Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. , 2012, The Journal of allergy and clinical immunology.

[78]  H. Spits,et al.  The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling , 2011, Nature Immunology.

[79]  茂呂 和世.  Innate production of T[H]2 cytokines by adipose tissue-associated c-Kit[+]Sca-1[+] lymphoid cells , 2010 .

[80]  D. Postma,et al.  The candidate gene approach in asthma: what happens with the neighbours? , 2010, European Journal of Human Genetics.

[81]  S. Akira,et al.  IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. , 2007, Journal of leukocyte biology.

[82]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .